Nifty

:

15904.35

Sensex

:

53029.15

-335.95 (-2.07%)
-1179.38 (-2.18%)

Login

Nifty
Sensex

:
:

15904.35
53029.15

-335.95 (-2.07%)
-1179.38 (-2.18%)

IOL Chemicals And Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :

45/99

BSE: 524164 | NSE: IOLCP

Watchlist

NSE BSE

398.95

18-May-2022

Open
High
Low
Previous Close

396.50
408.00
396.00
396.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

194913
782.85
725.00
292.80

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,340.88
10.98
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,976.14
1.50%
1.69

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.37
22.58
5.29

EBITDA CAGR (%)

10 Years
5 Years
3 Years

24.05
42.09
7.64

PAT CAGR (%)

10 Years
5 Years
3 Years

57.44
148.73
23.38

P:E (Median)

8 Years
5 Years
3 Years

7.87
9.52
8.28

P:BV (Average)

8 Years
5 Years
3 Years

2.95
2.95
2.95

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.35
5.85
4.87

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var%
Net Sales 555.14 513.01 8.21% 537.88 533.48 0.82% 518.51 460.11 12.69% 460.38 441.46 4.29%
Expenses 495.93 355.76 39.40% 494.08 362.18 36.42% 408.36 307.99 32.59% 349.21 304.61 14.64%
EBITDA 59.21 157.25 -62.35% 43.80 171.30 -74.43% 110.15 152.12 -27.59% 111.17 136.85 -18.77%
EBIDTM 10.67% 30.65% 8.14% 32.11% 21.24% 33.06% 24.15% 31.00%
Other Income 8.88 7.81 13.70% 10.51 4.48 134.60% 5.72 5.80 -1.38% 6.21 5.35 16.07%
Interest 2.29 1.46 56.85% 1.89 1.11 70.27% 1.77 1.82 -2.75% 1.44 2.76 -47.83%
Depreciation 11.13 9.97 11.63% 10.80 9.62 12.27% 10.32 9.36 10.26% 9.97 9.36 6.52%
PBT 54.67 153.63 -64.41% 41.62 165.05 -74.78% 89.85 146.74 -38.77% 105.97 130.08 -18.53%
Tax 14.60 38.82 -62.39% 10.78 38.09 -71.70% 22.85 19.20 19.01% 30.72 39.82 -22.85%
PAT 40.07 114.81 -65.10% 30.84 126.96 -75.71% 67.00 127.54 -47.47% 75.25 90.26 -16.63%
PATM 7.22% 22.38% 5.73% 23.80% 12.92% 27.72% 16.35% 20.45%
EPS 6.83 19.56 -65.08% 5.25 21.63 -75.73% 11.41 21.73 -47.49% 12.82 15.38 -16.64%

Description Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 2,071.91 1,966.98 1,894.47 1,685.33 983.30 710.65 580.42 384.73 563.50 481.51 470.68 Net Sales Growth 6.36% 3.83% 12.41% 71.40% 38.37% 22.44% 50.86% -31.72% 17.03% 2.30% Cost Of Goods Sold 1,419.48 1,102.84 1,065.01 1,047.25 695.28 477.40 416.20 279.34 369.54 300.23 299.77 Gross Profit 652.43 864.14 829.46 638.08 288.02 233.25 164.21 105.38 193.97 181.28 170.91 GP Margin 31.49% 43.93% 43.78% 37.86% 29.29% 32.82% 28.29% 27.39% 34.42% 37.65% 36.31% Total Expenditure 1,747.58 1,375.14 1,320.59 1,275.68 863.77 608.45 529.04 373.46 467.75 392.47 402.09 Power & Fuel Cost - 51.46 65.12 63.94 45.66 37.45 46.57 48.58 45.27 45.12 48.32 % Of Sales - 2.62% 3.44% 3.79% 4.64% 5.27% 8.02% 12.63% 8.03% 9.37% 10.27% Employee Cost - 115.55 97.20 78.43 56.10 43.18 35.13 24.72 27.08 22.08 20.14 % Of Sales - 5.87% 5.13% 4.65% 5.71% 6.08% 6.05% 6.43% 4.81% 4.59% 4.28% Manufacturing Exp. - 28.13 28.37 25.68 22.57 16.77 8.83 4.55 6.46 7.95 11.07 % Of Sales - 1.43% 1.50% 1.52% 2.30% 2.36% 1.52% 1.18% 1.15% 1.65% 2.35% General & Admin Exp. - 4.48 2.86 2.63 1.39 1.19 1.17 1.40 1.67 1.39 1.20 % Of Sales - 0.23% 0.15% 0.16% 0.14% 0.17% 0.20% 0.36% 0.30% 0.29% 0.25% Selling & Distn. Exp. - 50.78 48.45 46.72 33.73 20.81 12.81 6.39 11.27 0.00 0.00 % Of Sales - 2.58% 2.56% 2.77% 3.43% 2.93% 2.21% 1.66% 2.00% 0% 0% Miscellaneous Exp. - 21.90 13.58 11.03 9.04 11.65 8.33 8.48 6.47 15.70 0.00 % Of Sales - 1.11% 0.72% 0.65% 0.92% 1.64% 1.44% 2.20% 1.15% 3.26% 4.58% EBITDA 324.33 591.84 573.88 409.65 119.53 102.20 51.38 11.27 95.75 89.04 68.59 EBITDA Margin 15.65% 30.09% 30.29% 24.31% 12.16% 14.38% 8.85% 2.93% 16.99% 18.49% 14.57% Other Income 31.32 24.30 16.02 10.37 6.33 1.25 1.23 1.32 1.31 2.53 2.33 Interest 7.39 5.83 20.93 51.42 64.35 67.68 61.47 59.11 60.34 57.24 43.20 Depreciation 42.22 38.92 35.73 32.45 30.21 29.84 29.69 28.91 31.63 31.37 23.94 PBT 292.11 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 5.08 2.96 3.80 Tax 78.95 126.83 171.95 99.45 3.60 1.26 1.48 -8.79 1.78 1.37 -0.96 Tax Rate 27.03% 22.20% 32.25% 29.59% 11.50% 21.25% -3.84% 11.65% 35.04% 46.28% -25.26% PAT 213.16 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 3.30 1.59 4.75 PAT before Minority Interest 213.16 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 3.30 1.59 4.75 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.29% 22.60% 19.07% 14.04% 2.82% 0.66% -6.90% -17.32% 0.59% 0.33% 1.01% PAT Growth -53.62% 23.05% 52.64% 754.51% 493.15% - - - 107.55% -66.53% EPS 36.31 75.73 61.55 40.32 4.72 0.80 -6.82 -11.35 0.56 0.27 0.81

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 1,260.43 813.54 474.34 215.74 188.70 185.13 207.20 209.25 172.99 173.60 Share Capital 58.71 56.89 56.89 56.21 56.21 56.21 47.66 48.83 31.15 30.72 Total Reserves 1,201.72 747.33 408.13 159.53 132.49 128.92 153.56 160.42 141.84 142.45 Non-Current Liabilities 59.11 79.73 210.65 280.29 294.23 304.43 285.87 255.48 325.73 288.12 Secured Loans 0.00 0.00 189.88 236.16 262.37 283.25 253.84 163.91 202.96 198.26 Unsecured Loans 0.00 0.00 0.00 21.96 22.61 18.62 23.26 56.50 83.88 71.63 Long Term Provisions 3.68 3.85 4.59 2.04 1.50 1.18 0.30 0.30 0.13 0.12 Current Liabilities 432.80 453.63 324.79 350.97 327.67 282.92 208.54 276.82 228.54 225.83 Trade Payables 238.83 180.38 120.27 157.61 149.84 115.68 70.25 120.36 95.38 79.41 Other Current Liabilities 41.00 34.46 63.88 50.97 35.84 30.03 17.81 58.57 35.46 69.29 Short Term Borrowings 0.00 55.92 67.72 135.27 140.77 137.09 120.44 96.96 97.16 76.48 Short Term Provisions 152.97 182.87 72.92 7.12 1.22 0.13 0.04 0.94 0.54 0.65 Total Liabilities 1,752.34 1,346.90 1,009.78 847.00 810.60 772.48 701.61 741.55 727.26 687.55 Net Block 512.36 469.04 411.72 405.64 373.88 399.50 402.82 410.60 430.41 461.98 Gross Block 677.69 595.78 503.91 465.53 403.77 619.96 594.29 569.47 557.84 558.99 Accumulated Depreciation 165.33 126.74 92.19 59.89 29.89 220.47 191.47 158.86 127.42 97.01 Non Current Assets 587.80 498.99 457.60 416.02 395.94 415.63 418.12 460.38 475.91 487.70 Capital Work in Progress 48.27 19.19 27.02 6.95 21.26 4.31 4.21 33.06 31.51 12.38 Non Current Investment 0.00 0.00 0.00 0.00 0.05 0.04 0.04 0.00 0.00 0.00 Long Term Loans & Adv. 1.60 1.33 11.56 1.26 0.38 9.01 10.75 13.08 11.92 11.01 Other Non Current Assets 25.57 9.43 7.30 2.17 0.37 2.77 0.30 3.63 2.07 2.34 Current Assets 1,164.54 847.91 552.18 430.98 414.66 356.86 283.49 281.17 251.35 199.85 Current Investments 1.22 0.05 0.06 0.06 0.05 0.05 0.01 0.00 0.00 0.00 Inventories 295.15 187.52 188.86 207.45 262.63 227.94 213.42 192.23 163.47 131.77 Sundry Debtors 300.31 272.42 199.16 146.14 112.77 87.26 32.67 49.26 35.82 21.59 Cash & Bank 364.74 154.65 29.60 17.32 16.81 11.94 12.70 11.45 12.39 8.70 Other Current Assets 203.12 24.40 7.62 3.22 22.40 29.67 24.68 28.25 39.66 37.80 Short Term Loans & Adv. 164.60 208.87 126.88 56.79 18.79 26.78 22.19 25.37 36.98 35.95 Net Current Assets 731.74 394.28 227.39 80.01 86.99 73.93 74.95 4.35 22.82 -25.97 Total Assets 1,752.34 1,346.90 1,009.78 847.00 810.60 772.49 701.61 741.55 727.26 687.55

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 379.78 470.80 273.17 119.72 83.34 17.70 -46.96 78.40 53.19 54.91 PBT 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 5.08 2.96 3.80 Adjustment 27.15 51.93 82.35 91.64 95.92 83.92 81.73 86.38 83.25 63.48 Changes in Working Capital -76.51 2.78 -77.64 3.14 -17.45 -27.67 -52.83 -12.31 -32.25 -11.39 Cash after chg. in Working capital 522.03 587.95 340.86 126.08 84.40 17.70 -46.54 79.15 53.96 55.89 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -142.25 -117.15 -67.69 -6.36 -1.06 0.00 -0.42 -0.75 -0.76 -0.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -317.25 -184.23 -63.04 -50.38 -22.78 -27.37 -4.79 -12.12 -17.97 -86.88 Net Fixed Assets -110.99 -84.04 -58.45 -47.45 199.24 -25.77 4.03 -13.18 -17.98 -93.94 Net Investments -1.17 0.01 0.00 0.04 -0.01 -0.04 -0.05 0.00 0.00 0.00 Others -205.09 -100.20 -4.59 -2.97 -222.01 -1.56 -8.77 1.06 0.01 7.06 Cash from Financing Activity -58.28 -271.89 -197.46 -70.36 -59.78 9.27 49.69 -65.68 -31.80 23.05 Net Cash Inflow / Outflow 4.25 14.68 12.67 -1.02 0.78 -0.40 -2.07 0.60 3.42 -8.92 Opening Cash & Equivalents 28.09 13.41 0.74 1.76 0.98 1.38 15.06 14.46 11.03 19.94 Closing Cash & Equivalent 32.34 28.09 13.41 0.74 1.76 0.98 12.99 15.06 14.46 11.03

Financial Ratios

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 214.69 141.36 81.74 38.38 33.57 32.94 42.22 65.67 64.24 65.39 ROA 28.69% 30.66% 25.50% 3.34% 0.59% -5.43% -9.24% 0.45% 0.22% 0.74% ROE 43.06% 56.93% 69.54% 13.70% 2.50% -20.72% -34.14% 1.85% 0.95% 2.85% ROCE 54.20% 68.09% 55.53% 15.03% 11.57% 3.68% -2.78% 11.48% 10.55% 8.72% Fixed Asset Turnover 3.09 3.45 3.48 2.30 1.51 1.06 0.73 1.11 0.96 1.03 Receivable days 53.14 45.43 37.39 47.21 47.21 33.98 35.12 24.85 19.63 19.04 Inventory Days 44.78 36.26 42.92 85.71 115.79 125.04 173.90 103.91 100.92 83.51 Payable days 69.37 41.74 37.73 62.92 46.31 3.40 9.79 8.96 18.14 19.56 Cash Conversion Cycle 28.55 39.95 42.57 69.99 116.69 155.61 199.24 119.80 102.41 82.98 Total Debt/Equity 0.00 0.07 0.61 1.96 2.37 2.44 1.99 1.71 2.31 2.28 Interest Cover 99.01 26.48 7.54 1.49 1.09 0.37 -0.28 1.08 1.05 1.09

Top Investors:

vasudeva commercials limited

trichit limited

ashish kacholia

g consultants and fabricators ltd

pinebridge global funds - pinebridge india equity fund

Annual Reports:

News Update:

IOL Chemicals and Pharmaceuticals incorporates wholly owned subsidiary company
16th Mar 2022, 16:57 PM

The company has incorporated wholly owned subsidiary company to promote and support CSR activities
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback